Molecular mechanisms underlying the potential neuroprotective effects of Trifolium pratense and its phytoestrogen-isoflavones in neurodegenerative disorders.
The review article discusses the potential neuroprotective properties of phytoestrogen-isoflavones present in Trifolium pratense (Red clover) for the treatment of neurodegenerative disorders. Studies have shown that Trifolium pratense contains more than 30 isoflavone compounds, including biochanin A, daidzein, formononetin, and genistein. These compounds have been found to exhibit therapeutic efficacy against different neurodegenerative disorders through molecular interactions with estrogenic receptors, anti-inflammatory, anti-oxidative, antiapoptotic, and autophagic inducing mechanisms. The review provides detailed molecular mechanisms and experimental key findings for the clinical use of Trifolium pratense-derived isoflavones for the treatment of neurodegenerative disorders.
- Al-Shami AS, Essawy AE and Elkader HAEA (2023).
- Phytother Res.
- DOI:
- 10.1002/ptr.7870
- PubMed:
- 37195042